Donor hepatitis-C seropositivity is an independent risk factor for the development of accelerated coronary vasculopathy and predicts outcome after cardiac transplantation

Showkat A. Haji, Randall C. Starling, Robin K. Avery, Steven Mawhorter, E. Murat Tuzcu, Paul Schoenhagen, Daniel J. Cook, Norman B. Ratliff, Patrick M. McCarthy, James B. Young, Mohamad H. Yamani*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

100 Scopus citations

Fingerprint

Dive into the research topics of 'Donor hepatitis-C seropositivity is an independent risk factor for the development of accelerated coronary vasculopathy and predicts outcome after cardiac transplantation'. Together they form a unique fingerprint.

Medicine & Life Sciences